Skip to main content
Erschienen in: BMC Public Health 1/2022

Open Access 01.12.2022 | Research

Role of no table salt on hypertension and stroke based on large sample size from National Health and Nutrition Examination Survey database

verfasst von: Zongqin Li, Lan Hu, Xiaoxia Rong, Jun Luo, Xuejie Xu, Yonglong Zhao

Erschienen in: BMC Public Health | Ausgabe 1/2022

Abstract

Background

To assess the associations between no table salt and hypertension or stroke.

Methods

The data of 15,352 subjects were collected from National Health and Nutrition Examination Survey (NHANES) database. All subjects were divided into no hypertension or stroke group (n = 10,894), hypertension group (n = 5888), stroke group (n = 164) and hypertension and stroke group (n = 511). Univariate and multivariate logistic regression analysis was used to measure the associations of salt type used with hypertension and stroke and co-variables were respectively adjusted in different models.

Results

After adjusting age and gender, other salt intake was associated with 1.88-fold risk of hypertension (OR = 1.88, 95%CI: 1.44–2.46) and no table salt was associated with 1.30-fold risk of hypertension (OR = 1.30, 95%CI: 1.15–1.47). After adjusting age, gender, race, BMI, PIR, marital status, CVDs, whether doctors’ told them to reduce salt, and diabetes, the risk of hypertension was 1.23-fold increase in no table salt group (OR = 1.23, 95%CI: 1.04–1.46). After the adjustment of age and gender, the risk of hypertension and stroke was 3.33-fold increase (OR = 3.33, 95%CI: 2.12–5.32) in other salt intake group and 1.43-fold increase (OR = 1.43, 95%CI:1.17–1.74) in no table salt group.

Conclusion

Other salt intake or no table salt were associated with a higher risk of hypertension or hypertension and stroke.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12889-022-13722-8.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
NHANES
National Health and Nutrition Examination Survey
BMI
Body mass index
CVD
Cardiovascular diseases
CHD
Coronary heart disease
WHO
World Health Organization
PIR
Poverty income ratio
MEC
Mobile Examination Centers
Mean ± SD
Mean ± standard deviation
OR
Odds ratio
CI
confidence intervals

Background

Hypertension is reported to be a major cause of premature deaths and a heavy burden of cardiovascular morbidity and mortality, which resulted in approximately 7.1 million deaths and an estimated cost of $48.6 billion ever year [1]. Hypertension is widely validated to increase the risk of developing cardiovascular diseases (CVD) such as coronary heart disease (CHD) and stroke [2, 3]. Hypertension has strong associations with atherosclerosis deposits blocking and narrowing brain arteries, which has become a major risk factor for the occurrence of stroke [4, 5]. Stroke is reported to be the leading cause of death in China and the second leading cause of death all through the world [6]. Stroke is also the main reason of long-term neurological disability in adults, which leads to a substantial economic burden to the society and a decreased quality of life in patients [7]. Considering the considerable amount of economic burden to the family and society, more effective health care planning and prevention of hypertension and stroke are necessary.
Currently, some researches proposed that lifestyle changes may have significant effects on blood pressure control [8]. As high salt intake was reported to be associated with the risk of hypertension and cardiovascular events, restricting dietary salt has been proposed to be a method for hypertension prevention [9, 10]. Salt reduction was considered to be an important dietary target for 2025 to reduce the mortality of main noncommunicable diseases by the World Health Organization (WHO) [11]. In recent years, low-salt diet or event no-salt diet was advocated to improve health and prevent some diseases [12]. Previously, a study reported that about 10% of the sodium intake comes from discretionary salt use including table salt and salt added while cooking, which can be controlled by individuals [13]. For some people, to control salt use in daily life indicated low salt or no salt indicate adding low or no salt at table, and some other people added lite salt or salt substitute at table. Lite salt or salt substitute refer to sodium chloride in traditional salt is partially replaced with potassium chloride or magnesium sulfate, which are considered as a strategy under consideration by several countries for lowing blood pressure [14]. At present, various studies have explored the associations between sodium intake and the risk of hypertension or stroke [3, 15]. High sodium intake was associated with increased risk of hypertension or stroke. People was advocated to reduced salt use. But for common people, monitoring the salt contributions of specific foods and food groups, differentiating the inherent and processing-added sodium content of foods or other dietary sources were difficult [13]. It is easier for controlling the discretionary salt use including table salt and salt added while cooking to achieve the sodium intake reduction. Previous studies were focused on the volume of salt intake with the risk of hypertension and stroke, whether the different types of salt used just at table or during cooking were associated with the risk of hypertension or stroke were still unclear. Thus, the associations of doesn’t add salt product or adding different varieties of salt at the table or during cooking in hypertension or stroke still needs investigation, which might provide a guide for salt use in common people in the prevention of hypertension stroke.
In the current study, the associations of different salt types added at table or no table salt with the occurrence of hypertension and stroke were assessed based on the data from National Health and Nutrition Examination Survey (NHANES) database.

Methods

Study population

The NHANES database included a multifaceted health examination on a nationally representative sample of the civilian, non-institutionalized population in the United States based on complex multistage stratified probability sampling methods [16]. NHANES data is publicly available and the data collection and data release were approved by the National Center for Health Statistics (NCHS) Ethics Review Board [17]. The current study collected the clinical data of 22,564 participants aged > 20 years from the NHANES database from 2011 to 2018. After excluding participants without data on salt intake, and baseline characteristics including poverty income ratio (PIR), history of diabetes, body mass index (BMI), sodium and marital status, 15,352 subjects were involved in. All subjects were divided into no hypertension or stroke group (n = 9297), hypertension group (n = 4661), stroke group (n = 340) and hypertension and stroke group (n = 1054). The detailed screen process was shown in Fig. 1.

Main variables and outcome variables

The data of all participants were collected and analyzed including age, gender, BMI (kg/m2, < 18.5 kg/m2, 18.5–24.9 kg/m2, 25.0–29.9 kg/m2 or ≥ 30.0 kg/m2), race (Mexican American, other Hispanic, non-Hispanic White, non-Hispanic Black or other), education level (less than 9th grade, 9-11th grade, high school graduate, some college, or college graduate), marital status (married, widowed, divorced, separated, never married and living with partner), and PIR, history of diabetes, history of cardiovascular diseases (CVDs; congestive heart failure, coronary heart disease, angina/angina pectoris and heart attack), whether the participant’s doctor told them to reduce salt intake, type of table salt used (ordinary salt, other salt or no table salt).

Data measurement and variable definition

In NHANES database, health questionnaires were collected from all subjects in their home, and physical, laboratory and anthropometric examinations were performed in Mobile Examination Centers (MEC) by well-trained health technicians following standardized procedures.
People with hypertension, stroke, or hypertension and stroke were measured as outcome variables. Hypertension was defined as self-reported physician diagnosis, mean systolic blood pressure ≥ 140 mmHg or mean diastolic blood pressure ≥ 90 mmHg or use of antihypertensive medication [18]. Data from the Medical Conditions Questionnaire (MCQ160f) were applied to identify stroke diagnosis. Participants who replied “Yes” to the question “Has a doctor or other health professional ever told you that you had stroke?” were identified as stroke survivors [19]. Those who replied to have difficulties causing by stroke problems based on the Physical Functioning Questionnaire (PFQ) (063A-063E) were also defined to have stroke [20].
Hypertension and stroke was defined according to the self-reported physician diagnosis of both hypertension and stroke.
No table salt referred to no salt used or added at the table and in food preparation in household. Ordinary salt includes regular iodized salt, sea salt and seasoning salts made with regular salt, indicating using or adding these kinds of salt at the table or while cooking. Other salt indicated the lite salt or salt substitute at the table or while cooking. Potassium intake were calculated from the in-person 24-h dietary recall interview which was administered by trained interviewers using the USDA automated multiple-pass method [21, 22].
All subjects were asked to list all food and beverages consumed in the 24-h period from midnight to midnight on the day before the interview. The NHANES calculates the nutrient intake from food and beverage data based on the USDA’s Food and Nutrient Database for Dietary Studies (FNDDS) [23]. The FNDDS uses food composition data from the USDA National Nutrient Database or Standard Reference [24]. At the end of the dietary recall, participants were asked questions about discretionary salt use. The questions are:
1.
What type of salt do you usually add to food at the table? Would you say ordinary salt (includes regular iodized salt, sea salt, and seasoning salts made with regular salt), lite salt, salt substitute, don’t use or add salt at the table, other, don’t know?
 
2.
How often do you add ordinary salt to food at the table? Would you say rarely, occasionally, very often, refused, don’t know?
 
3.
How often is ordinary salt or seasoned salt added in cooking or preparing foods in your household? Is it never, rarely, occasionally, very often, or you don’t know?
 
Another variable including the data on salt use from the NHANES was DR2SKY with the questions of salt used at table yesterday? (Did {you/SP} add any salt to {your/her/his} food at the table yesterday? Salt includes ordinary or seasoned salt, lite salt, or a salt substitute.) and what type of salt was it? (Was it ordinary or seasoned salt, lite salt, or a salt substitute?).
The BMI in all people was divided into four groups: malnutrition group (< 18.5 kg/m2), normal weight group (18.5–24.9 kg/m2), overweight group (25.0–29.9 kg/m2) or obesity group (≥ 30.0 kg/m2).

Statistical analysis

All statistical tests were conducted by two-sided test. The sample data were subjected to a weighted manner to all analyses to account for the cluster sample design, oversampling, poststratification, survey nonresponse and sampling frame, and the weights were taken from sdmvstra, sdmvpsu and wtmec2yr variables in the NHANES database [25]. The mobile examination center (MEC) exam weight (wtmec2yr variables) was applied for weighting. The variable name for the masked variance unit pseudo-stratum was sdmvstra and the variable name for the masked variance unit pseudo-primary sampling units (PSUs) was sdmvpsu. The weight of the survey enabled it to be extended to the civilian noninstitutionalized US population. Sampling errors were calculated to determining their statistical reliability [26]. The measurement data of normal distribution were described by Mean ± standard deviation (Mean ± SD), the independent sample t test was applied for comparisons between groups. The non-normal distributed data were expressed by M (Q1, Q3), and differences between groups were compared by the Mann–Whitney U rank sum test. The enumeration data were described as n (%) and comparison of different groups was performed by chi-square test. Logistic regression analysis was used to measure the associations of salt types with hypertension and stroke. The odds ratios (ORs) and confidence intervals (CIs) were employed for evaluating the reliability of an estimate. As for different types of salt intake, three models were established: Crude model: the model without adjustment; Model 1: adjusted for age and gender; Model 2: adjusted for age, gender, race, BMI and PIR. SAS 9.4 statistical analysis software was used for data analyzing. The svydesign and svyglm function in R package survey (4.02 version) was applied for logistic regression modeling and draw the forest plot. The detailed data analysis process was presented in Supplementary Fig. 1. P < 0.05 was considered as statistical difference.

Results

The characteristics of participants

In total, 22,564 subjects from NHANES between 2011 and 2018 were involved in this study. After excluding participants with incomplete data on salt intake (n = 3175) and subjects with incomplete data on PIR (n = 1740), history of diabetes (n = 5), BMI (n = 170), sodium (n = 2150) and marital status (n = 2), 15,352 subjects were finally included and were divided into no hypertension or stroke group (n = 9297), hypertension group (n = 4661), stroke group (n = 340) and hypertension and stroke group (n = 1054). Among them, 5062 people were aged 20–39 years, accounting for 32.97%, 5164 people aged 40–59 years, accounting for 33.64%; 4274 persons aged 60–79 years, accounting for 27.84% and 852 persons aged ≥ 80 years, accounting for 5.55%. There were 7302 (47.56%) males and 8050 (52.44%) females. The median PIR of all participants was 2.14. In the study population, 2144 (13.97%) people had diabetes, 12,795 (83.34%) people had no diabetes, and 413 (2.69%) people were in borderline. There were 5715 patients with hypertension, accounting for 37.23% and 1394 patients suffered from stroke, accounting for 9.08%. As for salt used, 9964 people used ordinary salt, accounting for 64.90%, 664 people used other salts (lite salt or salt substitute), accounting for 4.33% and 4724 people did not add salt at the table, accounting for 30.77% (Table 1).
Table 1
The baseline data of all participants in the study
Variables
Total (n = 15,352)
Age, n (%)
 20–39
5062 (32.97)
 40–59
5164 (33.64)
 60–79
4274 (27.84)
 ≥ 80
852 (5.55)
Gender, n (%)
 Male
7302 (47.56)
 Female
8050 (52.44)
Race, n (%)
 Mexican American
1906 (12.42)
 Other Hispanic
1493 (9.73)
 Non-Hispanic White
6223 (40.54)
 Non-Hispanic Black
3481 (22.67)
 Other
2249 (14.65)
Education level, n (%)
 Less than 9th grade
1086 (7.07)
 9-11th grade
1798 (11.71)
 High school graduate
3440 (22.41)
 Some college
4900 (31.92)
 College graduate
4128 (26.89)
Marital Status, n (%)
 Married
7879 (51.32)
 Widowed
1085 (7.07)
 Divorced
1728 (11.26)
 Separated
520 (3.39)
 Never married
2858 (18.62)
 Living with partner
1282 (8.35)
BMI (kg/m2), n (%)
 < 18.5
221 (1.44)
 18.5–24.9
4055 (26.41)
 25.0–29.9
4868 (31.71)
 ≥ 30.0
6208 (40.44)
PIR, M (Q1,Q3)
2.14 (1.11,4.12)
Diabetes, n (%)
 Yes
2144 (13.97)
 No
12,795 (83.34)
Borderline
413 (2.69)
CVDs, n (%)
 Yes
14,011 (91.26)
 No
1291 (8.41)
 Unknown
50 (0.33)
Reduce salt, n (%)
 Yes
3158 (20.57)
 No
8565 (55.79)
 Unknown
3629 (23.64)
Hypertension, n (%)
 Yes
5715 (37.23)
 No
9637 (62.77)
Stroke, n (%)
 Yes
13,958 (90.92)
 No
1394 (9.08)
Type of table salt used, n (%)
 Ordinary salt
9964 (64.90)
 Other Salt
664 (4.33)
 No table salt
4724 (30.77)
BMI body mass index, PIR poverty income ratio, CVDs cardiovascular diseases

Comparisons of characteristics of participants among different groups

All study population was divided into four groups, 9297 people were no hypertension or stroke, 4661 people were hypertension patients, 340 people were stroke patients, and 1054 people were hypertension and stroke patients, The results depicted that the proration of people in different age (χ2 = 3036.02, P < 0.001), race (χ2 = 354.30, P < 0.001), education level (χ2 = 361.77, P < 0.001), marital status (χ2 = 1041.96, P < 0.001), BMI (χ2 = 815.64, P < 0.001), PIR (χ2 = 260.78, P < 0.001), diabetes (χ2 = 1697.86, P < 0.001), CVDs, doctors told them to reduce salt and change type of table salt used (χ2 = 207.99, P < 0.001) groups among no hypertension or stroke, hypertension patients, hypertension and stroke patients were statistically different (Table 2).
Table 2
Comparisons of characteristics among different groups
Variables
No Hypertension or Stroke (n = 9297)
Hypertension (n = 4661)
Stroke (n = 340)
Hypertension and Stroke (n = 1054)
Statistic
P-value
Age (years), n (%)
    
χ2 = 3036.017
 < .001
 20–39
4352 (46.81)
628 (13.47)
47 (13.82)
35 (3.32)
  
 40–59
3182 (34.23)
1593 (34.18)
116 (34.12)
273 (25.90)
  
 60–79
1539 (16.55)
2022 (43.38)
135 (39.71)
578 (54.84)
  
 ≥ 80
224 (2.41)
418 (8.97)
42 (12.35)
168 (15.94)
  
Gender, n (%)
    
χ2 = 5.701
0.127
 Male
4420 (47.54)
2256 (48.40)
158 (46.47)
468 (44.40)
  
 Female
4877 (52.46)
2405 (51.60)
182 (53.53)
586 (55.60)
  
Race, n (%)
    
χ2 = 354.297
 < .001
 Mexican American
1317 (14.17)
450 (9.65)
40 (11.76)
99 (9.39)
  
 Other Hispanic
955 (10.27)
411 (8.82)
29 (8.53)
98 (9.30)
  
 Non-Hispanic White
3629 (39.03)
1937 (41.56)
183 (53.82)
474 (44.97)
  
 Non-Hispanic Black
1790 (19.25)
1359 (29.16)
52 (15.29)
280 (26.57)
  
 Other
1606 (17.27)
504 (10.81)
36 (10.59)
103 (9.77)
  
Education level, n (%)
    
χ2 = 361.767
 < .001
 Less than 9th grade
556 (5.98)
352 (7.55)
38 (11.18)
140 (13.28)
  
 9-11th grade
982 (10.56)
567 (12.16)
67 (19.71)
182 (17.27)
  
 High school graduate
1950 (20.97)
1119 (24.01)
86 (25.29)
285 (27.04)
  
 Some college
2933 (31.55)
1549 (33.23)
89 (26.18)
329 (31.21)
  
 College graduate
2876 (30.93)
1074 (23.04)
60 (17.65)
118 (11.20)
  
Marital Status, n (%)
    
χ2 = 1041.964
 < .001
 Married
4725 (50.82)
2555 (54.82)
159 (46.76)
440 (41.75)
  
 Widowed
325 (3.50)
508 (10.90)
44 (12.94)
208 (19.73)
  
 Divorced
866 (9.31)
607 (13.02)
55 (16.18)
200 (18.98)
  
 Separated
280 (3.01)
172 (3.69)
19 (5.59)
49 (4.65)
  
 Never married
2180 (23.45)
528 (11.33)
41 (12.06)
109 (10.34)
  
 Living with partner
921 (9.91)
291 (6.24)
22 (6.47)
48 (4.55)
  
BMI (kg/m2), n (%)
    
χ2 = 815.638
 < .001
 < 18.5
176 (1.89)
34 (0.73)
3 (0.88)
8 (0.76)
  
 18.5–24.9
3059 (32.90)
745 (15.98)
82 (24.12)
169 (16.03)
  
 25.0–29.9
3016 (32.44)
1501 (32.20)
89 (26.18)
262 (24.86)
  
 ≥ 30.0
3046 (32.76)
2381 (51.08)
166 (48.82)
615 (58.35)
  
PIR, M (Q1,Q3)
2.27 (1.15,4.30)
2.20 (1.18,4.25)
1.35 (0.91,2.48)
1.42 (0.88,2.48)
χ2 = 260.784
 < .001
Diabetes, n (%)
    
χ2 = 1697.862
 < .001
 Yes
556 (5.98)
1046 (22.44)
90 (26.47)
452 (42.88)
  
 No
8585 (92.34)
3414 (73.25)
240 (70.59)
556 (52.75)
  
 Borderline
156 (1.68)
201 (4.31)
10 (2.94)
46 (4.36)
  
CVDs, n (%)
    
χ2 = 1478.690
 < .001
 Yes
9052 (97.36)
4058 (87.06)
269 (79.12)
632 (59.96)
  
 No
232 (2.50)
585 (12.55)
68 (20.00)
406 (38.52)
  
 Unknown
13 (0.14)
18 (0.39)
3 (0.88)
16 (1.52)
  
Reduce salt, n (%)
    
χ2 = 2010.879
 < .001
 Yes
922 (9.92)
1712 (36.73)
64 (18.82)
460 (43.64)
  
 No
6251 (67.24)
1882 (40.38)
162 (47.65)
270 (25.62)
  
 Unknown
2124 (22.85)
1067 (22.89)
114 (33.53)
324 (30.74)
  
Type of table salt used, n (%)
    
χ2 = 207.986
 < .001
 Ordinary Salt
6394 (68.77)
2755 (59.11)
239 (70.29)
576 (54.65)
  
 Other Salt
305 (3.28)
263 (5.64)
15 (4.41)
81 (7.69)
  
 No table salt
2598 (27.94)
1643 (35.25)
86 (25.29)
397 (37.67)
  
BMI body mass index, PIR poverty income ratio, CVDs cardiovascular diseases

Multivariate logistic regression analysis

Compared with people consuming ordinary salt, the risk of hypertension was 2.09-fold increased (OR = 2.09, 95%CI: 1.61–2.71) in other salt intake group and 1.39-fold increased (OR = 1.39, 95%CI: 1.3–1.57) in no table salt group. After adjusting age and gender, other salt intake was associated with 1.88-fold risk of hypertension (OR = 1.88, 95%CI: 1.44–2.46) and no table salt was associated with 1.30-fold risk of hypertension (OR = 1.30, 95%CI: 1.15–1.47). After adjusting age, gender, race, BMI, PIR, marital status, CVDs, whether doctors’ told them to reduce salt and diabetes, the risk of hypertension was 1.23-fold increase in no table salt group (OR = 1.23, 95%CI: 1.04–1.46). Compared with those with ordinary salt at table, the risk of stroke in ordinary salt group or no table salt group was not statistically different (Fig. 2).
In comparison with people with ordinary salt at table, the risk of hypertension and stroke was 4.09-fold increase (OR = 4.09, 95%CI: 2.61–6.43) in other salt intake group and 1.61-fold increase (OR = 1.61, 95%CI: 1.32–1.95) in no table salt group. Post adjusting age and gender, the risk of hypertension and stroke was 3.33-fold increase (OR = 3.33, 95%CI: 2.12–5.32) in other salt intake group and 1.43-fold increase (OR = 1.43, 95%CI:1.17–1.74) in no table salt group. After adjusting age, gender, race, BMI, PIR, marital status, CVDs, whether doctors’ told them to reduce salt and diabetes, other salt intake and no table salt was not statistically associated with risk of hypertension and stroke (all P > 0.05) (Fig. 2).

Discussion

In the present study, the data of 15,352 participants were collected from the NHANES database to analyze the associations of salt types added at table with hypertension and stroke. The result delineated that other salt intake or no table salt might be associated with an increased risk of hypertension. Other salt intake or no table salt might be also associated with an increased risk of hypertension and stroke. The findings of our study might give a reference for the use of salt at table in preventing the occurrence of hypertension and stroke and improving the prognosis of patients with hypertension or hypertension and stroke.
Currently, salt substitutes are used to replace ordinary salt (100% sodium chloride) where a portion of sodium is replaced with potassium chloride (usually 25%-30%) and/or magnesium sulphate (10%-14%). Several meta-analyses involving randomized controlled trials (RCTs) revealed that salt substitutes application decreased the systolic blood pressure and diastolic blood pressure in patients with hypertension [27]. Salt substitute might be an accessible and effective method for reducing the risk of death caused by stroke in patients with hypertension [28]. In this study, patients with other salt intake (lite salt or salt substitute) were associated with a higher risk of hypertension or hypertension and stroke. Some studies have indicated that people may prefer the taste of ordinary salt to salt substitutes and some people do not accept the taste of salt substitutes, so when they use salt substitutes, they might use more amount of salt, which actually resulted in a high sodium intake [29]. In addition, we found for people with more salt substitutes at table, the potassium intake was lower than those with ordinary salt intake (Supplementary Fig. 2). Previous studies have revealed that potassium is an essential nutrient and the addition of a high potassium diet could reduce the blood pressure in people [30, 31]. Also, some randomized controlled trials indicated that higher potassium intake could lower the blood pressure in those with hypertension [32]. Therefore, adequate potassium supplement was recommended in people especially hypertension people.
As for people do not add salt product at the table, excessive low salt diet might cause salt-sensitivity hypertension, as long-term low sodium intake might result in the high sensitivity to salt in human body and increased sodium intake might stimulate the secretions of hormones such as epinephrine and angiotensin, which led to hypertension [33]. Salt-sensitivity hypertension was a potential area requiring validation for further research, as some other researchers indicated that although a high-salt diet might increase the accumulation of sodium, the expansion of volume, and the adjustment of cardiac outputs, the autoregulation might maintain the flow via increasing the systemic vascular resistance, and causing the kidneys to excrete more salt and water, and therefore reducing systems to normal and minimizing the changes in blood pressure [34]. Another study also depicted that sodium reduction only decreased the blood pressure in participants with a blood pressure in the highest 25th percentile of all population and the author also suggested to reframe the policy of lowering dietary sodium intake in the general population and hypertension patients [35]. Sodium is main extracellular cation in the body to maintain intravascular volume, which is required in human body and salt restriction in humans may cause some adverse effects [36]. A previous study also reported that salt-deficient diet promoted cystogenesis in ARPKD via epithelial sodium channel [37]. Besides, people might intake more sodium rather than eat at table. Nowadays, commercial products infiltrate sodium insensibly into our nutrition and the involuntary sodium intake was high in daily life [38]. People who used other salt or do not add salt at table might prefer other commercial products with high sodium.
The findings of our study suggested that adding ordinary salt at table with appropriate volume is recommended for the prevention of hypertension. In addition, for people with hypertension or hypertension and stroke, adding lower volume of ordinary salt at table as well as enough potassium supplement were necessary for blood pressure control. This study measured the associations of salt with hypertension and stroke based on the data of 15,352 subjects from NHANES database. Our study involved in a large sample size and subgroup analysis was conducted in different types of salt, which might increase the reliability of our results. The findings of our study might provide a reference for the salt use at table or during cooking for common people. Several limitations existed in the current study. Firstly, the participants included in NHANES database were mainly from western countries, and whether the findings were suitable for people from oriental countries still needs validation in more studies. Secondly, the sample size in other salt group was small, which might decrease the statistical power. Thirdly, all data were collected from NHANES database, and important variables such as 24-h urine sodium of participants were not evaluated; the outcome variables were self-reported, which might cause bias. Fourthly, the self-reports of prior stroke in the NHANES stroke data represents a sample of stroke survivors, and we couldn’t analyze the data on those with acute stroke die, or are disabled to the extent that they are hospitalized, home-bound or institutionalized in long term care facilities. In the future, RCTs including large scale of sample size were required to verify the results in this study.

Conclusions

This study analyzed the associations of different salt types and no table salt with hypertension and stroke based on the data of 15,352 subjects NHANES database. The results delineated that no table salt was associated with a higher risk of hypertension or hypertension and stroke. The findings suggested that salt intake is important and required in common people and in patients with hypertension or hypertension with stroke, necessary ordinary salt intake and enough potassium intake were required to control the blood pressure.

Acknowledgements

None.

Declarations

Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441–50.CrossRef Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441–50.CrossRef
2.
Zurück zum Zitat Fan F, Yuan Z, Qin X, Li J, Zhang Y, Li Y, et al. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial). Hypertension. 2017;69(4):697–704.CrossRef Fan F, Yuan Z, Qin X, Li J, Zhang Y, Li Y, et al. Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial). Hypertension. 2017;69(4):697–704.CrossRef
3.
Zurück zum Zitat Rust P, Ekmekcioglu C. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension. Adv Exp Med Biol. 2017;956:61–84.CrossRef Rust P, Ekmekcioglu C. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension. Adv Exp Med Biol. 2017;956:61–84.CrossRef
4.
Zurück zum Zitat Chaudhary NS, Bridges SL Jr, Saag KG, Rahn EJ, Curtis JR, et al. Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study. Hypertension. 2020;75(1):246–56.CrossRef Chaudhary NS, Bridges SL Jr, Saag KG, Rahn EJ, Curtis JR, et al. Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study. Hypertension. 2020;75(1):246–56.CrossRef
5.
Zurück zum Zitat O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75.CrossRef O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75.CrossRef
6.
Zurück zum Zitat GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–58. GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–58.
7.
Zurück zum Zitat Aringazina A, Kuandikov T, Arkhipov V. Burden of the Cardiovascular Diseases in Central Asia. Cent Asian J Glob Health. 2018;7(1):321.PubMedPubMedCentral Aringazina A, Kuandikov T, Arkhipov V. Burden of the Cardiovascular Diseases in Central Asia. Cent Asian J Glob Health. 2018;7(1):321.PubMedPubMedCentral
8.
Zurück zum Zitat Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension. 2003;41(6):1178–9.CrossRef Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension. 2003;41(6):1178–9.CrossRef
9.
Zurück zum Zitat O’Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612–23.CrossRef O’Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612–23.CrossRef
10.
Zurück zum Zitat Strazzullo P, D’Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567.CrossRef Strazzullo P, D’Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567.CrossRef
11.
Zurück zum Zitat Beaglehole R, Bonita R, Horton R, Ezzati M, Bhala N, Amuyunzu-Nyamongo M, et al. Measuring progress on NCDs: one goal and five targets. Lancet. 2012;380(9850):1283–5.CrossRef Beaglehole R, Bonita R, Horton R, Ezzati M, Bhala N, Amuyunzu-Nyamongo M, et al. Measuring progress on NCDs: one goal and five targets. Lancet. 2012;380(9850):1283–5.CrossRef
12.
Zurück zum Zitat Khan MS, Jones DW, Butler J. Salt, No Salt, or Less Salt for Patients With Heart Failure? Am J Med. 2020;133(1):32–8.CrossRef Khan MS, Jones DW, Butler J. Salt, No Salt, or Less Salt for Patients With Heart Failure? Am J Med. 2020;133(1):32–8.CrossRef
13.
Zurück zum Zitat Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10(4):383–93.CrossRef Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10(4):383–93.CrossRef
14.
Zurück zum Zitat Zhou B, Webster J, Fu LY, Wang HL, Wu XM, Wang WL, Shi JP. Intake of low sodium salt substitute for 3years attenuates the increase in blood pressure in a rural population of North China - A randomized controlled trial. Int J Cardiol. 2016;215:377–82.CrossRef Zhou B, Webster J, Fu LY, Wang HL, Wu XM, Wang WL, Shi JP. Intake of low sodium salt substitute for 3years attenuates the increase in blood pressure in a rural population of North China - A randomized controlled trial. Int J Cardiol. 2016;215:377–82.CrossRef
15.
Zurück zum Zitat Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (Clinical research ed). 2013;346:f1326. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (Clinical research ed). 2013;346:f1326.
16.
Zurück zum Zitat Gallo S, Byham-Gray L, Duffy VB, Hoffman HJ, Hayes JE, Rawal S. Associations of olfactory dysfunction with anthropometric and cardiometabolic measures: Findings from the 2013–2014 national health and nutrition examination survey (NHANES). Physiol Behav. 2020;215: 112702.CrossRef Gallo S, Byham-Gray L, Duffy VB, Hoffman HJ, Hayes JE, Rawal S. Associations of olfactory dysfunction with anthropometric and cardiometabolic measures: Findings from the 2013–2014 national health and nutrition examination survey (NHANES). Physiol Behav. 2020;215: 112702.CrossRef
18.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.CrossRef Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.CrossRef
21.
Zurück zum Zitat Rehm CD, Peñalvo JL, Afshin A, Mozaffarian D. Dietary Intake Among US Adults, 1999–2012. JAMA. 2016;315(23):2542–53.CrossRef Rehm CD, Peñalvo JL, Afshin A, Mozaffarian D. Dietary Intake Among US Adults, 1999–2012. JAMA. 2016;315(23):2542–53.CrossRef
25.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). NCfHSN: National Health and Nutrition Examination Survey: analytic guidelines, 2011–2014 and 2015–2016. 2018. Centers for Disease Control and Prevention (CDC). NCfHSN: National Health and Nutrition Examination Survey: analytic guidelines, 2011–2014 and 2015–2016. 2018.
27.
Zurück zum Zitat Hernandez AV, Emonds EE, Chen BA, Zavala-Loayza AJ, Thota P, Pasupuleti V, et al. Effect of low-sodium salt substitutes on blood pressure, detected hypertension, stroke and mortality. Heart. 2019;105(12):953–60.PubMed Hernandez AV, Emonds EE, Chen BA, Zavala-Loayza AJ, Thota P, Pasupuleti V, et al. Effect of low-sodium salt substitutes on blood pressure, detected hypertension, stroke and mortality. Heart. 2019;105(12):953–60.PubMed
28.
Zurück zum Zitat Sun H, Ma B, Wu X, Wang H, Zhou B. Long-Term Effect of Salt Substitute on All-Cause and Cardiovascular Disease Mortality: An Exploratory Follow-Up of a Randomized Controlled Trial. Front Cardiovasc Med. 2021;8:645902.CrossRef Sun H, Ma B, Wu X, Wang H, Zhou B. Long-Term Effect of Salt Substitute on All-Cause and Cardiovascular Disease Mortality: An Exploratory Follow-Up of a Randomized Controlled Trial. Front Cardiovasc Med. 2021;8:645902.CrossRef
29.
Zurück zum Zitat Li N, Prescott J, Wu Y, Barzi F, Yu X, Zhao L, Neal B. The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern China. Br J Nutr. 2009;101(7):1088–93.CrossRef Li N, Prescott J, Wu Y, Barzi F, Yu X, Zhao L, Neal B. The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern China. Br J Nutr. 2009;101(7):1088–93.CrossRef
30.
Zurück zum Zitat Smiljanec K, Mbakwe A, Ramos Gonzalez M, Farquhar WB, Lennon SL. Dietary Potassium Attenuates the Effects of Dietary Sodium on Vascular Function in Salt-Resistant Adults. Nutrients. 2020;12(5):1206.CrossRef Smiljanec K, Mbakwe A, Ramos Gonzalez M, Farquhar WB, Lennon SL. Dietary Potassium Attenuates the Effects of Dietary Sodium on Vascular Function in Salt-Resistant Adults. Nutrients. 2020;12(5):1206.CrossRef
31.
Zurück zum Zitat Stone MS, Martyn L, Weaver CM. Potassium Intake, Bioavailability, Hypertension, and Glucose Control. Nutrients. 2016;8(7):444.CrossRef Stone MS, Martyn L, Weaver CM. Potassium Intake, Bioavailability, Hypertension, and Glucose Control. Nutrients. 2016;8(7):444.CrossRef
32.
Zurück zum Zitat Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ (Clinical research ed). 2013;346:f1378. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ (Clinical research ed). 2013;346:f1378.
33.
Zurück zum Zitat Chatelanat O, Pechère-Bertschi A, Ponte B. Salt sensitivity and hypertension. Rev Med Suisse. 2019;15(662):1625–8.PubMed Chatelanat O, Pechère-Bertschi A, Ponte B. Salt sensitivity and hypertension. Rev Med Suisse. 2019;15(662):1625–8.PubMed
34.
Zurück zum Zitat Titze J, Luft FC. Speculations on salt and the genesis of arterial hypertension. Kidney Int. 2017;91(6):1324–35.CrossRef Titze J, Luft FC. Speculations on salt and the genesis of arterial hypertension. Kidney Int. 2017;91(6):1324–35.CrossRef
35.
Zurück zum Zitat Graudal N, Hubeck-Graudal T, Jürgens G, Taylor RS. Dose-response relation between dietary sodium and blood pressure: a meta-regression analysis of 133 randomized controlled trials. Am J Clin Nutr. 2019;109(5):1273–8.CrossRef Graudal N, Hubeck-Graudal T, Jürgens G, Taylor RS. Dose-response relation between dietary sodium and blood pressure: a meta-regression analysis of 133 randomized controlled trials. Am J Clin Nutr. 2019;109(5):1273–8.CrossRef
36.
Zurück zum Zitat Nishimuta M, Kodama N, Yoshitake Y, Shimada M, Serizawa N. Dietary Salt (Sodium Chloride) Requirement and Adverse Effects of Salt Restriction in Humans. J Nutr Sci Vitaminol (Tokyo). 2018;64(2):83–9.CrossRef Nishimuta M, Kodama N, Yoshitake Y, Shimada M, Serizawa N. Dietary Salt (Sodium Chloride) Requirement and Adverse Effects of Salt Restriction in Humans. J Nutr Sci Vitaminol (Tokyo). 2018;64(2):83–9.CrossRef
37.
Zurück zum Zitat Ilatovskaya DV, Levchenko V, Pavlov TS, Isaeva E, Klemens CA, Johnson J, et al. Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC). EBioMedicine. 2019;40:663–74.CrossRef Ilatovskaya DV, Levchenko V, Pavlov TS, Isaeva E, Klemens CA, Johnson J, et al. Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC). EBioMedicine. 2019;40:663–74.CrossRef
38.
Zurück zum Zitat Goldstein P, Leshem M. Dietary sodium, added salt, and serum sodium associations with growth and depression in the U.S. general population. Appetite. 2014;79:83–90.CrossRef Goldstein P, Leshem M. Dietary sodium, added salt, and serum sodium associations with growth and depression in the U.S. general population. Appetite. 2014;79:83–90.CrossRef
Metadaten
Titel
Role of no table salt on hypertension and stroke based on large sample size from National Health and Nutrition Examination Survey database
verfasst von
Zongqin Li
Lan Hu
Xiaoxia Rong
Jun Luo
Xuejie Xu
Yonglong Zhao
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2022
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-022-13722-8

Weitere Artikel der Ausgabe 1/2022

BMC Public Health 1/2022 Zur Ausgabe